The Clorox Company $CLX Shares Acquired by Culbertson A N & Co. Inc.

Culbertson A N & Co. Inc. increased its stake in shares of The Clorox Company (NYSE:CLX) by 4.7% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 14,867 shares of the company’s stock after acquiring an additional 670 shares during the quarter. Culbertson A N & Co. Inc.’s holdings in Clorox were worth $1,785,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Horizon Investments LLC increased its position in shares of Clorox by 4.4% during the first quarter. Horizon Investments LLC now owns 1,768 shares of the company’s stock worth $258,000 after purchasing an additional 75 shares in the last quarter. Sfmg LLC grew its stake in Clorox by 2.8% during the 1st quarter. Sfmg LLC now owns 2,780 shares of the company’s stock worth $409,000 after buying an additional 76 shares during the last quarter. Hancock Whitney Corp increased its position in Clorox by 4.3% during the first quarter. Hancock Whitney Corp now owns 2,064 shares of the company’s stock worth $304,000 after buying an additional 86 shares during the period. Brown Lisle Cummings Inc. lifted its stake in Clorox by 4.3% in the second quarter. Brown Lisle Cummings Inc. now owns 2,136 shares of the company’s stock valued at $256,000 after buying an additional 89 shares during the last quarter. Finally, American National Bank & Trust boosted its holdings in shares of Clorox by 69.5% in the second quarter. American National Bank & Trust now owns 217 shares of the company’s stock valued at $26,000 after acquiring an additional 89 shares during the period. 78.53% of the stock is owned by hedge funds and other institutional investors.

Insider Activity at Clorox

In related news, COO Eric H. Reynolds sold 15,041 shares of the firm’s stock in a transaction dated Thursday, September 4th. The shares were sold at an average price of $123.78, for a total value of $1,861,774.98. Following the completion of the sale, the chief operating officer owned 54,221 shares in the company, valued at $6,711,475.38. This trade represents a 21.72% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. 0.63% of the stock is owned by company insiders.

Clorox Stock Performance

NYSE CLX opened at $101.23 on Tuesday. The stock has a market capitalization of $12.35 billion, a price-to-earnings ratio of 15.53, a PEG ratio of 0.92 and a beta of 0.52. The business’s 50 day moving average is $117.18 and its two-hundred day moving average is $123.22. The Clorox Company has a 12-month low of $101.11 and a 12-month high of $171.37. The company has a current ratio of 0.84, a quick ratio of 0.57 and a debt-to-equity ratio of 5.15.

Clorox (NYSE:CLX) last posted its quarterly earnings results on Monday, November 3rd. The company reported $0.85 earnings per share for the quarter, beating analysts’ consensus estimates of $0.78 by $0.07. The firm had revenue of $1.43 billion for the quarter, compared to the consensus estimate of $1.41 billion. Clorox had a return on equity of 377.86% and a net margin of 11.40%.The company’s revenue for the quarter was down 18.9% compared to the same quarter last year. During the same period in the previous year, the business earned $1.86 earnings per share. Clorox has set its FY 2026 guidance at 5.950-6.300 EPS. Research analysts expect that The Clorox Company will post 7.15 EPS for the current year.

Clorox Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Thursday, November 6th. Stockholders of record on Wednesday, October 22nd were issued a $1.24 dividend. This represents a $4.96 dividend on an annualized basis and a dividend yield of 4.9%. The ex-dividend date was Wednesday, October 22nd. Clorox’s dividend payout ratio (DPR) is currently 77.86%.

Analyst Upgrades and Downgrades

A number of equities analysts have recently commented on the stock. UBS Group set a $119.00 target price on shares of Clorox and gave the company a “neutral” rating in a report on Tuesday, November 4th. Zacks Research lowered shares of Clorox from a “hold” rating to a “strong sell” rating in a research note on Tuesday, October 28th. Weiss Ratings reiterated a “hold (c-)” rating on shares of Clorox in a research note on Tuesday, October 14th. The Goldman Sachs Group dropped their price target on Clorox from $115.00 to $110.00 and set a “sell” rating on the stock in a research report on Wednesday, October 1st. Finally, Rothschild & Co Redburn decreased their price objective on Clorox from $120.00 to $115.00 and set a “neutral” rating for the company in a research report on Wednesday, November 5th. One analyst has rated the stock with a Buy rating, twelve have given a Hold rating and five have assigned a Sell rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of “Reduce” and an average target price of $125.69.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.